05
2023
-
12
Haizhi Biotechnology participated in the seminar on "Research and Development of Dressings for Protection Against Skin Radiation Damage."
Haizhi Bio participated in the seminar on the research and development of "Protective Dressings for Skin Radiation Injury".
On December 1, 2023, the Tianjin Medical Device Review and Inspection Center held a project conclusion seminar for the research group on "Protective Dressings for Skin Radiation Injury," with our company participating as a corporate representative.
Haizhi Bio focuses on the repair of skin and mucosal injuries, with a layout in transdermal drug delivery and health care for skin and mucosa. The company also pays close attention to the research of medical devices for skin injury protection. Haizhi Bio participates in seminars organized by regulatory authorities to fully understand the development specifications of such products and provides professional opinions, helping regulatory authorities understand corporate needs while allowing the company to deeply comprehend regulatory norms, thus facilitating high-quality project establishment and research advancement.

About Haizhi Bio: Jiangsu Haizhi Biological Pharmaceutical Co., Ltd. is located in Nanjing Jiangbei New District (referred to as Haizhi Bio). It is a comprehensive high-tech enterprise integrating research and development, production, and sales. The company focuses on the repair of skin and mucosal injuries, with a layout in transdermal drug delivery and health care for skin and mucosa. Currently, the main business operations include the research and development, production, and sales of medical devices, cosmetics, and other series of products. The company has established a complete range of Class II medical devices and functional skincare products and is advancing into Class III medical devices and drug-device combinations, preparing for industrialization. Haizhi Bio has successively obtained a series of independent research and development achievements, applied for 27 patents, registered 76 trademarks, and registered over 20 Class II medical device products. Since 2018, it has been recognized as a private technology enterprise in Jiangsu Province, a national/Jiangsu Province/Nanjing City high-tech enterprise, a technology-based small and medium-sized enterprise, and a "specialized, refined, distinctive, and innovative" small and medium-sized enterprise in Nanjing.


More news